WELL Health Technologies Corp.
TSX:WELL.TO · Toronto Stock Exchange
+$0.02 today
Vol 1.26M · Avg 1.62M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-5.8%
avg 56.9%
ROIC
5.1%
avg -216.9%
ROA
-2.4%
avg -126.4%
Analysis
ROIC is currently the strongest return metric at 5.1% versus its period average of -216.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Hamed Shahbazi | Founder, Chairman & Chief Executive Officer | $950,000.00 | — | 51 | — | — |
James T. Kreger | Chief Executive Officer of WELL Health USA & CRH Medical | $849,024.00 | — | 57 | — | — |
Dina Sergi | Chief Executive Officer of MyHealth Partners Inc. | $679,255.00 | — | — | — | — |
Bill Crawford | Chief Financial Officer of CRH | $573,098.00 | — | — | — | — |
Michael Frankel | Chief Medical Officer | $423,976.00 | — | — | — | — |
Eva Fong | Chief Financial Officer | $270,000.00 | — | — | — | — |
Amir Javidan | Chief Operating Officer | $265,000.00 | — | — | — | — |
Derek Clark | Chief Operating Officer | $265,000.00 | — | — | — | — |
Brian Eric Levinkind | Senior Vice President of Corporate Development | $216,000.00 | — | 60 | — | — |
Pardeep S. Sangha | Vice President of Corporate Strategy & Investor Relations | — | — | — | — | — |
Shane Joseph Sabatino | Chief People Officer | — | — | — | — | — |
Ric Leong | Chief Accounting Officer | — | — | — | — | — |
Chris Ericksen | Senior Vice President of Strategic Partnerships & Marketing | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +107.3% (12yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Forward estimates point to Revenue at +107.3% (12yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
Extendicare Inc.
TSX:EXE.TO
$3.21B
Trulieve Cannabis Corp.
TRUL.CN
$2.74B
Sienna Senior Living Inc.
TSX:SIA.TO
$2.16B
dentalcorp Holdings Ltd.
DNTL.TO
$2.10B
Cronos Group Inc.
TSX:CRON.TO
$1.40B
Verano Holdings Corp.
VRNO.NE
$594.30M
Cresco Labs Inc.
CL.CN
$407.36M
Medical Facilities Corporation
TSX:DR.TO
$315.20M
Quipt Home Medical Corp.
QIPT.TO
$221.44M
Premier Health of America Inc.
PHA.V
$555,142.00
Who manages WELL.TO?
WELL Health Technologies Corp. (WELL.TO) lists 13 active executives. The top listed executive is Hamed Shahbazi, Founder, Chairman & Chief Executive Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.